Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 220 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
Journal Article
Sharaf RN, Khullar D, Umscheid CA.  2020.  Health Technology Assessment Centers-an Infrastructure for Health Systems to Translate Evidence into Practice.. J Gen Intern Med. 35(4):1296-1299.
Kern LM, Rajan M, Pincus HA, Casalino LP, Stuard SS.  2019.  Health Care Fragmentation in Medicaid Managed Care vs. Fee-for-Service.. Popul Health Manag.
Grinspan ZM, Eldar YC, Gopher D, Gottlieb A, Lammfromm R, Mangat HS, Peleg N, Pon S, Rozenberg I, Schiff ND et al..  2016.  Guiding Principles for a Pediatric Neurology ICU (neuroPICU) Bedside Multimodal Monitor: Findings from an International Working Group.. Appl Clin Inform. 7(2):380-98.
Jung H-Y, Unruh MA, Kaushal R, Vest JR.  2015.  Growth Of New York Physician Participation In Meaningful Use Of Electronic Health Records Was Variable, 2011-12.. Health Aff (Millwood). 34(6):1035-43.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Rieß HChristian, Debus ESebastian, Schwaneberg T, Sedrakyan A, Kölbel T, Tsilimparis N, Larena-Avellaneda A, Behrendt C-A.  2019.  Gender disparities in fenestrated and branched endovascular aortic repair.. Eur J Cardiothorac Surg. 55(2):338-344.
Weiss P, Myers AL, McGann KA, Mason KE, Kesselheim JC, Fleming G, Barron C, Klasner A, Heyman MB, Weiss DL et al..  2019.  Funding Sources and Perceived Financial Insecurity in Pediatric Subspecialty Fellowship Programs.. Acad Pediatr. 19(7):815-821.
Weiss P, Myers AL, McGann KA, Mason KE, Kesselheim JC, Fleming G, Barron C, Klasner A, Heyman MB, Weiss DL et al..  2019.  Funding Sources and Perceived Financial Insecurity in Pediatric Subspecialty Fellowship Programs.. Acad Pediatr. 19(7):815-821.
Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC.  2019.  Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.. JAMA Surg.
Tagawa ST, Antonarakis ES, Gjyrezi A, Galletti G, Kim S, Worroll D, Stewart J, Zaher A, Szatrowski TP, Ballman KV et al..  2019.  Expression of AR-V7 and ARv in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY.. Clin Cancer Res. 25(6):1880-1888.
Tagawa ST, Antonarakis ES, Gjyrezi A, Galletti G, Kim S, Worroll D, Stewart J, Zaher A, Szatrowski TP, Ballman KV et al..  2019.  Expression of AR-V7 and ARv in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY.. Clin Cancer Res. 25(6):1880-1888.
Tagawa ST, Antonarakis ES, Gjyrezi A, Galletti G, Kim S, Worroll D, Stewart J, Zaher A, Szatrowski TP, Ballman KV et al..  2019.  Expression of AR-V7 and ARv in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY.. Clin Cancer Res. 25(6):1880-1888.
Varma JK, Zang C, Carton TW, Block JP, Khullar DJ, Zhang Y, Weiner MG, Rothman RL, Schenck EJ, Xu Z et al..  2023.  Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program.. medRxiv.
Varma JK, Zang C, Carton TW, Block JP, Khullar DJ, Zhang Y, Weiner MG, Rothman RL, Schenck EJ, Xu Z et al..  2023.  Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program.. medRxiv.
Ghomrawi HMK, Mushlin AI, Kang R, Banerjee S, Singh JA, Sharma L, Flink C, Nevitt M, Neogi T, Riddle DL.  2020.  Examining Timeliness of Total Knee Replacement Among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal Cohorts.. J Bone Joint Surg Am. 102(6):468-476.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR.  2019.  Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR.  2019.  Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.
Mullangi S, Kaushal R, Ibrahim SA.  2019.  Equity in the Age of Health Care Information Technology and Innovation: Addressing the Digital Divide.. Med Care. 57 Suppl 6 Suppl 2:S106-S107.